The latest myeloma news
Multiple myeloma remains challenging to treat. New therapeutic advances have improved outcomes, but selecting the right…
A new research perspective was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Preclinical and clinical…
A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Centre at the University of…
In the first clinical trial of an immunotherapy agent for people with high-risk smouldering myeloma…
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe…
A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
A new agent that subverts myeloma cells from within while also subjecting them to an…
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine,…
A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new…
The European Commission (EC) has granted the approval of a type II variation application for…